Tags : Leronlimab


CytoDyn Signs an Agreement with American Regent for Leronlimab to

Shots: CytoDyn to receive quarterly payments based on the profit-sharing arrangement and will supply Leronlimab to American Regent. American Regent will be responsible for the distribution of Leronlimab post completion of CytoDyn’s ongoing clinical trials including the FDA’s approval in the US CytoDyn’s P-IIb/III trial is enrolling patients which will be evaluating leronlimab vs PBO […]Read More